Literature DB >> 28985204

Noncoding RNAs as effective markers in cancer-care management.

Ivan Raimondi1, Maite Huarte1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28985204     DOI： 10.1038/nm.4423

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

Review 1.  The emerging role of lncRNAs in cancer.

Authors:  Maite Huarte
Journal:  Nat Med       Date:  2015-11       Impact factor: 53.440

2.  Joint analysis of functional genomic data and genome-wide association studies of 18 human traits.

Authors:  Joseph K Pickrell
Journal:  Am J Hum Genet       Date:  2014-04-03       Impact factor: 11.025

Review 3.  Implementing personalized cancer genomics in clinical trials.

Authors:  Richard Simon; Sameek Roychowdhury
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

4.  Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.

Authors:  Daniel S W Tan; Fui Teen Chong; Hui Sun Leong; Shen Yon Toh; Dawn P Lau; Xue Lin Kwang; Xiaoqian Zhang; Gopinath M Sundaram; Gek San Tan; Mei Mei Chang; Boon Tin Chua; Wan Teck Lim; Eng Huat Tan; Mei Kim Ang; Tony K H Lim; Prabha Sampath; Balram Chowbay; Anders J Skanderup; Ramanuj DasGupta; N Gopalakrishna Iyer
Journal:  Nat Med       Date:  2017-09-18       Impact factor: 53.440

5.  Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

Authors:  Andre T Baron; Elsa M Cora; Jacqueline M Lafky; Cecelia H Boardman; Marites C Buenafe; Alfred Rademaker; Dachao Liu; David A Fishman; Karl C Podratz; Nita J Maihle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-02       Impact factor: 4.254

6.  Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.

Authors:  Elodie Bal; Hyun-Sook Park; Zakia Belaid-Choucair; Hülya Kayserili; Magali Naville; Marine Madrange; Elena Chiticariu; Smail Hadj-Rabia; Nicolas Cagnard; Francois Kuonen; Daniel Bachmann; Marcel Huber; Cindy Le Gall; Francine Côté; Sylvain Hanein; Rasim Özgür Rosti; Ayca Dilruba Aslanger; Quinten Waisfisz; Christine Bodemer; Olivier Hermine; Fanny Morice-Picard; Bruno Labeille; Frédéric Caux; Juliette Mazereeuw-Hautier; Nicole Philip; Nicolas Levy; Alain Taieb; Marie-Françoise Avril; Denis J Headon; Gabor Gyapay; Thierry Magnaldo; Sylvie Fraitag; Hugues Roest Crollius; Pierre Vabres; Daniel Hohl; Arnold Munnich; Asma Smahi
Journal:  Nat Med       Date:  2017-09-04       Impact factor: 53.440

7.  Novel actin-related proteins Arp-T1 and Arp-T2 as components of the cytoskeletal calyx of the mammalian sperm head.

Authors:  Hans Heid; Ulrike Figge; Stefanie Winter; Caecilia Kuhn; Ralf Zimbelmann; Werner Franke
Journal:  Exp Cell Res       Date:  2002-10-01       Impact factor: 3.905

Review 8.  Essentials of oral cancer.

Authors:  César Rivera
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Oral cavity and oropharyngeal squamous cell carcinoma--an update.

Authors:  Angela C Chi; Terry A Day; Brad W Neville
Journal:  CA Cancer J Clin       Date:  2015-07-27       Impact factor: 508.702

10.  Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib?

Authors:  M G Zampino; E Magni; L Santoro; L Zorzino; P Dell'Orto; A Sonzogni; N Fazio; L Monfardini; A Chiappa; R Biffi; F de Braud
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-08       Impact factor: 3.333
  10 in total
  1 in total

1.  The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2.

Authors:  Wei Xiang; Lei Lyu; Tao Huang; Fuxin Zheng; Jingdong Yuan; Chuanhua Zhang; Guosong Jiang
Journal:  J Cell Mol Med       Date:  2020-09-04       Impact factor: 5.310
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.